• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Healthcare Bioconvergence Companies

    ID: MRFR/HC/10078-HCR
    128 Pages
    Kinjoll Dey
    October 2025

    "Healthcare bioconvergence" is a term that may not be widely associated with specific companies or a well-defined industry sector. However, the concept of bioconvergence generally refers to the convergence of various disciplines within the life sciences and healthcare sectors.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Healthcare Bioconvergence Market

    Healthcare Bioconvergence Key Companies

     


    Latest Healthcare Bioconvergence Companies Update:

    BiomX (microbiome therapeutics) Received a Therapeutics Development Award of up to $5 million from the Cystic Fibrosis Foundation to develop phage therapies for cystic fibrosis.


    Century Therapeutics (cell therapy) Collaborated with Bristol Myers Squibb to commercialize IPSC-derived allogenic cell-based therapies, strengthening their position in personalized medicine.


    Abu Dhabi Department of Health and Israel Innovation Authority Partnered to work on critical health innovation projects, including proof-of-concept and clinical trials.


    Life Arc (UK medical research firm) Funded $5.74 million for the Gen OMICC COVID-19 project, supporting patient enrollment, sample collection, and bioinformatics analysis.


    List of Healthcare Bioconvergence Key companies in the market

    • Ginkgo Bioworks (US)

    • Thermo Fisher Scientific Inc. (US)

    • GE Healthcare (US)

    • Siemens (Germany)

    • BiomX (Israel)

    • Century Therapeutics (US)

    • Singota Solutions (US)

    • Galvani Bioelectronics (UK)

    • Bico Group (US)

    • SetPoint Medical (US)